We showed B55i can disrupt the Eya3 and PP2A–B55α interaction in vitro, and B55i expressed on a plasmid can increase Myc pT58 and reduce Myc protein level in TNBC cells, illustrating its potential as a cancer therapy. This evidence concerns the gene EYA3 and cancer.